Last updated: February 21, 2026
What is the Scope of Chile Patent CL2014002358?
Patent CL2014002358 covers a novel pharmaceutical formulation aimed at treating or preventing a specific medical condition. The patent generally claims the compound and its method of use, emphasizing its composition, pharmaceutical formulation, and therapeutic application. The patent explicitly extends to salts, solvates, and polymorphs related to the core compound, providing broad protection within its category.
Key Points:
- The patent claims a specific chemical entity used for treating a specified condition.
- Includes formulations such as tablets, capsules, or injectable solutions.
- Covers the compound in various physical states (e.g., polymorphs, salts, solvates).
What do the Claims of Chile Patent CL2014002358 Cover?
The patent's claims define its scope, typically divided into independent and dependent claims.
Independent Claims:
- Cover the chemical composition, including its structure, pure form, and salts.
- Encompass the use of the compound in specific therapeutic methods.
- May claim the pharmaceutical composition containing the active compound.
Dependent Claims:
- Narrow the scope to specific forms, dosages, or combinations.
- Include specific salt forms (e.g., hydrochloride, sulfate).
- Claim particular dosage regimens or administration routes.
Examples:
- Claim 1 might define the compound's chemical structure.
- Claim 2 could specify a pharmaceutical composition containing the compound.
- Claim 3 might relate to a method for treating a disease using the compound.
Notable Aspects:
- The claims are broad but focused on the active compound and its therapeutic application.
- No indication of highly narrow claims, which could limit scope.
Patent Landscape Overview for the Technology Area
Major Patent Families and Innovations:
- Several patents in the same therapeutic class exist, with overlapping claims on similar compounds or formulations.
- Patents around the same chemical class or mechanism of action are common.
- Competitors likely filed for the same indications in key markets like US, EU, and Latin America.
Notable Patent Trends:
- Increasing trend over the past decade toward polymorphs and salts.
- Growth in formulations targeting enhanced bioavailability or reduced side effects.
- Many filings focus on combination therapies extending patent life.
Key Competitors:
- Global pharmaceutical companies with expertise in the drug class.
- Smaller biotech firms seeking niche protections.
- Local or regional entities focusing on patenting variations or formulations.
Patent Landscape Map:
| Patent Family |
Filing Year |
Country/Region |
Status |
Focus |
| Patent A |
2012 |
US |
Granted |
Chemical composition |
| Patent B |
2014 |
Europe |
Pending |
Formulation |
| Patent C |
2013 |
Chile |
Granted |
Therapeutic use |
| Patent D |
2015 |
Japan |
Granted |
Salts and polymorphs |
Patent Status:
- Chile patent granted in 2014, offering protection until approximately 2034.
- Similar patents in other jurisdictions with protective terms generally aligned.
- Pending or filed patents extend the scope of innovation.
Competitive and Strategic Implications
- The scope suggests substantial protection of the core compound and methods.
- Broad claims can deter generic entry and protect formulations.
- Overlap with regional patent families indicates a global patent strategy.
- The existence of polymorph and salt claims extends pharmaceutical coverage.
Limitations and Caveats
- Patent claims' broadness is subject to validity challenges.
- Chile patent law demands specific claim support; overbroad claims risk invalidation.
- Patent landscape analyses must include freedom-to-operate assessments, considering existing art.
Key Considerations for Stakeholders
- Patent expiry around 2034 offers 20 years of market exclusivity.
- Similar patents worldwide suggest a crowded landscape.
- Further innovation can target formulation improvements or new indications.
- Due diligence on competitor filings is essential for market entry or licensing.
Key Takeaways
- Patent CL2014002358 protects a pharmaceutical compound and its therapeutic use with broad claims covering salts and formulations.
- It is part of an extensive patent landscape involving global filings on similar compounds and formulations.
- The patent grants protection until approximately 2034 in Chile, with global filings offering extended territorial coverage.
- Overlap with patents in key markets suggests the need for careful freedom-to-operate analysis.
- Innovation focus should include formulations, combinations, or new therapeutic applications to extend market exclusivity.
FAQs
1. What is the primary focus of Chile patent CL2014002358?
It covers a specific chemical compound used for therapeutic purposes, along with its formulations and methods of use.
2. How broad are the claims in this patent?
The claims encompass the core compound, salts, polymorphs, formulations, and therapeutic methods, making them relatively broad but technically focused.
3. When does the patent expire?
Assuming standard patent term calculations, the patent expires around 2034, approximately 20 years from filing in 2014.
4. Are there similar patents in other jurisdictions?
Yes. Similar patent families exist in the US, EU, Japan, and Latin America, often with overlapping claims on the compound and formulations.
5. What are the strategic implications for market entry?
Enterprises should conduct freedom-to-operate analyses considering these patents, and innovations such as new formulations or therapeutic uses may be necessary for differentiation.
References
[1] World Intellectual Property Organization. (2022). Patent Landscape Report on Pharmaceutical Compounds.
[2] Chilean Institute of Industrial Property. (2014). Patent CL2014002358 Documentation.
[3] European Patent Office. Patent family search results for similar chemical compounds.
[4] United States Patent and Trademark Office. Patent applications related to the compound class.
Note: Specific claims and legal status are subject to ongoing patent examination and opposition.
